AstraZeneca's Cancer Drug Could Secure FDA Approval Despite Final Trial Let-Down

阿斯利康的癌症藥物可能會獲得FDA的批准，儘管最終試驗結果令人失望

WSJ · 09/23 21:14

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.